Journal September 25, 2026 5 min read

Common Misconceptions About Synovial Fluid

Synovial fluid is not a simple joint lubricant. This research-use-only review corrects common misconceptions and summarises what the evidence shows about its composition, markers and models.

peptides-pro Editorial

What synovial fluid actually is

Synovial fluid is the viscous, non-Newtonian ultrafiltrate of plasma that occupies the joint cavity, also called synovia. It is not a single molecule and has no sequence, formula or molecular weight; it is a biological fluid whose principal macromolecular component is hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan. Its diagnostic and research value comes from what it contains: cells, proteins, cytokines and degradation products that reflect the state of the synovium and cartilage.

The pathway most often examined in this literature is the inflammatory cytokine network, particularly tumour necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta), together with the NLRP3 inflammasome and its adaptor TXNIP.

Research Studies

Hyaluronic acid injection and TNF-alpha / IL-1 beta in knee osteoarthritis

A registered clinical study is determining the effect of intra-articular HA injection therapy on pre- and post-treatment TNF-alpha and IL-1 beta levels, and on methylation changes, in blood and synovial fluid of patients with knee osteoarthritis, compared with a placebo group. The same study evaluates pain, functional status and quality of life and relates these to the cytokine changes [3].

REJENERA and the NLRP3-TXNIP-iNOS axis in a rat osteoarthritis model

REJENERA, a multi-component bioflavonoid-based formula, was studied for its effect on osteoarthritis and chondroprotection via regulation of the NLRP3-TXNIP-iNOS axis and inflammation. The formula contains primarily olive leaf bioflavonoids (ZeyEX, quercetin and luteolin), S-allylcysteine, palmitoylethanolamide, L-proline, hyaluronic acid and boron. In a rat model in which osteoarthritis was established by intra-articular injection of monosodium iodoacetate (MIA; 3 mg) into the right knee joint, the study compared REJENERA with ZeyEX, NPROC (collagen-rich eggshell membrane combined with olive leaf extract) and ibuprofen [1]. This is animal-model evidence.

Collagen peptide supplementation and connective tissue remodelling after total knee arthroplasty

A registered trial is examining the effects of collagen peptide supplementation on connective tissue remodelling, functional outcomes and wound healing after total knee arthroplasty. Recruitment is performed by clinical staff reviewing scheduled procedures and electronic medical records, with electronic consent through REDCap [2].

Autologous bone marrow aspirate and combined LAM + LP-PRP in knee osteoarthritis

The ABLE OA trial is a Health Canada authorised phase II/III, multi-centre, prospective, double-blinded, randomised, placebo-controlled adaptive trial. It evaluates two minimally manipulated autologous cellular preparations: bone marrow aspirate (BMA) injection, and combined lipoaspirate micronized (LAM) plus leukocyte-poor platelet-rich plasma (LP-PRP) injections, for knee osteoarthritis. Preparations are made using the Cervos Marrow Cellution Bone Marrow Aspiration System, Cervos LIPO-PRO Adipose Transfer System and Cervos KEYPRP Platelet Separator System [4].

Serum and synovial markers in periprosthetic joint infection

A diagnostic clinical study is evaluating the diagnostic accuracy and cost-effectiveness of combining serum and/or synovial markers in the diagnosis of periprosthetic joint infection (PJI) in patients hospitalised for revision surgery. The project addresses open questions about the diagnostic accuracy of these markers [6].

Alpha-defensin and synovial proteins in paediatric septic arthritis

Differentiating septic arthritis from other causes of joint inflammation in paediatric patients is challenging. The current gold standard is a positive synovial fluid culture, but cultures may take several days, and surgeons frequently must decide whether to debride a joint before results are available. No single laboratory test or clinical feature reliably distinguishes the two, which is the gap this study addresses using alpha-defensin and synovial proteins [8].

Acthar and synovial inflammation in rheumatoid arthritis

In a study of synovial inflammation in rheumatoid arthritis, patients are assigned to receive either Depo Medrol or Acthar. Synovial biopsy, blood draws, synovial fluid aspiration and physician assessments are performed before and after initiating treatment [7].

Borrelia B-cell diagnostics and synovial-adjacent immune testing

The BRILLIANT study is a single-centre, prospective observational study in children with Lyme disease. It assesses the immune response against Borrelia burgdorferi, with the development of a Bb-specific ASC ELISpot as a new test method for diagnosis of early Lyme disease, addressing the low sensitivity of standard two-tier testing in recently infected patients and false positives in recovered patients from long-term antibody persistence [5].

Comparison of synovial fluid study models

Model / population	Intervention or marker	Key measured outcome
Rat knee OA (MIA-induced)	REJENERA vs ZeyEX, NPROC, ibuprofen	NLRP3-TXNIP-iNOS axis, inflammation, chondroprotection [1]
Human knee OA	Intra-articular HA vs placebo	TNF-alpha, IL-1 beta, methylation, pain and function [3]
Human knee OA	BMA vs saline; LAM + LP-PRP vs saline	Efficacy of autologous cellular preparations [4]
Human revision arthroplasty	Serum and synovial markers	Diagnostic accuracy and cost-effectiveness in PJI [6]
Paediatric joint inflammation	Alpha-defensin and synovial proteins	Detection of septic arthritis [8]

Equine and human synovial fluid findings

An equine randomised controlled trial investigated the short-term effects of intra-articular allogenic platelet-rich plasma in the lipopolysaccharide (LPS) model of joint inflammation, using a preliminary 0.0625 ng LPS dose in the middle carpal joint compared within animal to a saline control to confirm synovitis [9]. A separate study examined the association between smoking history and inflammatory biomarkers in synovial fluid of patients undergoing arthroscopic knee surgery for meniscal injury, addressing how patient smoking affects the intra-articular microenvironment in symptomatic meniscal tears [10].

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only. We do not provide dosing or medical guidance, and nothing on this page is a treatment recommendation. Anyone considering a compound for themselves should speak to a licensed clinician.